Literature DB >> 20920867

Autism in monogenic disorders.

Katarzyna Kotulska1, Sergiusz Jóźwiak.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 20920867     DOI： 10.1016/j.ejpn.2010.08.007

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN： 1090-3798            Impact factor:   3.140


× No keyword cloud information.
  4 in total

Review 1.  The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies.

Authors:  Meera E Modi; Larry J Young
Journal:  Horm Behav       Date:  2011-12-20       Impact factor: 3.587

2.  Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110β-selective inhibitor.

Authors:  Christina Gross; Gary J Bassell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 3.  Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms.

Authors:  Ece D Gamsiz; Laura N Sciarra; Abbie M Maguire; Matthew F Pescosolido; Laura I van Dyck; Eric M Morrow
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD).

Authors:  Martha Spilioti; Athanasios E Evangeliou; Despoina Tramma; Zoe Theodoridou; Spyridon Metaxas; Eleni Michailidi; Eleni Bonti; Helen Frysira; A Haidopoulou; Despoina Asprangathou; Aggelos J Tsalkidis; Panagiotis Kardaras; Ron A Wevers; Cornelis Jakobs; K Michael Gibson
Journal:  Front Hum Neurosci       Date:  2013-12-24       Impact factor: 3.169
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.